| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbdae384a9f1ad0588422c89ddc71a00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7dfb0281008cb570feea037cd350c8f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 |
| filingDate |
2018-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9aafb5a5623e0660ed2821e9d9d5678
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dd9e8abf09d64f94ee8ec1d73ed55a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f9b5e21a2f3e9eb1e1b8228e9073ff7 |
| publicationDate |
2020-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3648787-A1 |
| titleOfInvention |
Treatment of patients with severe von willebrand disease undergoing elective surgery by administration of recombinant vwf |
| abstract |
The present invention relates to a method of pretreatment of a subject with severe form of von Willebrand disease prior to surgery to administer to the subject a dose in the range of about 20 IU / kg to about 60 IU / kg rVWF (recombinant von Willebrand factor) between about 12 hours and about 24 hours before surgery, and factor VIII not being administered with rVWF prior to surgery. |
| priorityDate |
2017-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |